Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers for early detection of sepsis

Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers for early detection of sepsis

US Patent 12123881 · Granted Oct 22, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of GTPases and their use2025
Treatment of cancer utilizing an identified adenosine fingerprint2025
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2025
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2025
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2025
Modulators of GTPases and their use2023
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2021
Modulators of GTPases and their use2020
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2019
Activated GTPase-based assays and kits for the diagnosis of sepsis and other inf2019